AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD

Sanjay Sethi,1 Edward Kerwin,2 Henrik Watz,3 Gary T Ferguson,4 Robert M Mroz,5,6 Rosa Segarra,7 Eduard Molins,7 Diana Jarreta,7 Esther Garcia Gil7 1Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, USA; 2Clinical Research Institute, Medford, OR, USA; 3Pulmo...

Full description

Bibliographic Details
Main Authors: Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:International Journal of COPD
Subjects:
aclidinium bromide
bronchodilators
LAMA
LABA
24-hour lung function
Online Access:https://www.dovepress.com/amplify-a-randomized-phase-iii-study-evaluating-the-efficacy-and-safet-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/amplify-a-randomized-phase-iii-study-evaluating-the-efficacy-and-safet-peer-reviewed-article-COPD

Similar Items